NUMA1 antibody
Quick Overview for NUMA1 antibody (ABIN3025682)
Target
See all NUMA1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- PEG precipitation
-
Immunogen
- Colon carcinoma 174T cells were used as the immunogen for the NuMA antibody.
-
Isotype
- IgM kappa
-
-
-
-
Application Notes
-
Optimal dilution of the NuMA antibody should be determined by the researcher.
1. Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 10-20 min followed by cooling at RT for 20 min.\. Western blot: 1-2 μg/mL,Immunofluorescence: 0.5-1 μg/mL,Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT (1)
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the NuMA antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
-
- NUMA1 (Nuclear Mitotic Apparatus Protein 1 (NUMA1))
-
Alternative Name
- NuMA
-
Background
- Recognizes a phosphorylated protein of 228 kDa, identified as nuclear mitotic apparatus protein (NuMA). Its epitope is resistant to phosphatases. NuMA is intra-nuclear protein and present in nucleus during interphase. At the onset of mitosis, it redistributes from the nucleus to two centrosomal structures that later will become part of the mitotic spindle pole. After anaphase, the protein redistributes from the spindle polar region into reforming nucleus. NuMA is an essential protein during mitosis for the terminal phases of chromosome separation and/or nuclear reassembly. Recently a study shows that NuMA is cleaved to a 180 to 200 kDa during apoptosis. Chromosomal translocation of this gene with the RARA (retinoic acid receptor, alpha) gene on chromosome 17 has been detected in patients with acute promyelocytic leukemia.
-
Pathways
- Caspase Cascade in Apoptosis, Regulation of Actin Filament Polymerization, M Phase
Target
-